Barbara Nelsen
Direktor/Vorstandsmitglied bei SANY HEAL
Profil
Barbara Nelsen is the founder of Nelsen Biomedical LLC.
She currently holds director positions at Discovery Capital Fund, Regenerative Medicine Minnesota, Sanaby Health Acquisition Corp.
I, Anatomic Corp., and University Enterprise Labs.
Previously, she was an Associate Director of Business Development at MGI PHARMA, Director of Office Technology Commercialization at the University of Minnesota, and Director at B-MoGen Biotechnologies, Inc. Nelsen holds a doctorate from Brandeis University and a Master's in Business Administration from the University of St. Thomas.
Aktive Positionen von Barbara Nelsen
| Unternehmen | Position | Beginn |
|---|---|---|
| SANY HEAL | Direktor/Vorstandsmitglied | - |
| Anatomic Corp. | Direktor/Vorstandsmitglied | - |
| Discovery Capital Fund | Direktor/Vorstandsmitglied | - |
| University Enterprise Labs | Direktor/Vorstandsmitglied | - |
Regenerative Medicine Minnesota
 Regenerative Medicine Minnesota Miscellaneous Commercial ServicesCommercial Services Regenerative Medicine Minnesota is an initiative that provides biobusiness grants to develop businesses and infrastructure for delivering regenerative medicine products and services. The goal of this state-wide initiative is to create new economic opportunities by commercializing technologies and leveraging the strengths of Minnesota institutions to position the state as a leader in regenerative medicine. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Barbara Nelsen
| Unternehmen | Position | Ende |
|---|---|---|
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | Corporate Officer/Principal | 01.01.2009 |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Corporate Officer/Principal | - |
| Nelsen Biomedical LLC | Gründer | - |
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Direktor/Vorstandsmitglied | - |
Ausbildung von Barbara Nelsen
| Brandeis University | Doctorate Degree |
| University of St. Thomas | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Health Technology |
| Discovery Capital Fund | |
Regenerative Medicine Minnesota
Regenerative Medicine Minnesota Miscellaneous Commercial ServicesCommercial Services Regenerative Medicine Minnesota is an initiative that provides biobusiness grants to develop businesses and infrastructure for delivering regenerative medicine products and services. The goal of this state-wide initiative is to create new economic opportunities by commercializing technologies and leveraging the strengths of Minnesota institutions to position the state as a leader in regenerative medicine. | Commercial Services |
Sanaby Health Acquisition Corp. I
 Sanaby Health Acquisition Corp. I Financial ConglomeratesFinance Sanaby Health Acquisition Corp. I operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Sandra Shpilberg on April 8, 2021 and is headquartered in Palo Alto, CA. | Finance |
| Nelsen Biomedical LLC | |
| Anatomic Corp. | |
| University Enterprise Labs |
